GGrantIndex
← Leaderboards

Mitchell D Creinin

University Of Pittsburgh At Pittsburgh

Google Scholar ↗PubMed ↗ORCID ↗
$2,236,079
Attributed
$2,236,079
Total exposure
31
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $640.6K · FY2005–25
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$2,236,079 · 31

By mechanism

N01$1,348,587 · 5
M01$472,411 · 25
T32$415,081 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject”

Research focus

Human SubjectClinical ResearchFemaleHuman Therapy EvaluationWomen'S HealthDrug Screening /EvaluationClinical Trial Phase IProgestinsReproductive System PharmacologyQuestionnairesFemale Reproductive SystemContraceptivesLevonorgestrelNonoxynol 9Drug Administration RoutesDrug Administration Rate /DurationFemale Reproductive System Disorder DiagnosisSlow Release DrugVaginaOral AdministrationMethotrexateCombination ChemotherapyAbortifacientsNondrug Contraceptive

Grant awards (85)

NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: SEVERABLE$143,208
N01 · FY2025 · HD · contact PI
NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE CONTRACEPTIVE TRIALS TOPIC A$472,818
N01 · FY2010 · HD · contact PI
CONTRACEPTIVE EFFICACY EVALUATIONF OF THE PATH FEMALE CONDOM$640,561
N01 · FY2009 · HD · contact PI
NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK /FEMALE CONTRACEPTIVE TRIA-275003372$0
N01 · FY2006 · HD · contact PI
Ob-Gyn Fellowships in Epidemiology and Clinical Trials$140,451
T32 · FY2005 · HD
SAFETY ANALYSIS OF THE DIAPHRAGM IN COMBINATION WITH VAGINAL MICROBICIDE GELS$104,230
M01 · FY2005 · RR
A MULTICENTER,RANDOMIZED, DOUBLE-MASKED, COMPARATOR STUDY OF C31G VAGINAL GEL$60,424
M01 · FY2005 · RR
COMPARATIVE RESEARCH STUDY PATH WOMAN'S CONDOM AND THE FEMALE CONDOM$48,338
M01 · FY2005 · RR
STUDY OF BUFFERGEL SPERMICIDE USED WITH DIAPHRAGM COMPARED TO GYNOL II$16,655
M01 · FY2005 · RR
ESTRADIOL,PROGESTERONE,ETHINYL,ETONOGESTREL LEVELS IN WOMEN USING NUVARING$5,329
M01 · FY2005 · RR
PHASE I COMPARATIVE POST-COITAL TESTING AND SAFETY STUDY OF THE SILCS DIAPHRAGM$2,331
M01 · FY2005 · RR
A RANDOMIZED TRIAL ON MANAGEMENT OF EARLY PREGNANCY FAILURE$1,332
M01 · FY2005 · RR
Ob-Gyn Fellowships in Epidemiology and Clinical Trials$140,136
T32 · FY2004 · HD
Randomized Trial-- Management of Early Pregnancy Failure$80,892
M01 · FY2004 · RR
BufferGel Spermicide Used with Diaphragm vs Gynol II$53,673
M01 · FY2004 · RR
CDB-2914--10 mg to 50 mg CDB for Emergency Contraception$35,867
M01 · FY2004 · RR
SAFETY AND ACCEPTABILITY STUDY OF 6% CELLULOSE SULFATE$25,183
M01 · FY2004 · RR
Post-Coital Testing and Safety Study of SILCS Diaphragm$21,368
M01 · FY2004 · RR
PHASE I SAFETY/ACCEPTABILITY STUDY OF ACIDFORM GEL$14,245
M01 · FY2004 · RR
SAFETY &ACCEPTABILITY OF 10% POLYSTYRENE SULFONATE GEL$2,544
M01 · FY2004 · RR
Ob-Gyn Fellowships in Epidemiology and Clinical Trials$134,494
T32 · FY2003 · HD
CONTRACEPTIVE EFFECTIVENESS OF SLIP ON PLASTIC CONDOMS$0
M01 · FY2002 · RR
OUTPATIENT TO EVALUATE THE SAFETY OF NORPLANT II$0
M01 · FY2002 · RR
OUTPATIENT TO EVALUATE THE SAFETY OF NORPLANT II$0
M01 · FY2002 · RR
COMPARISON OF MEDICAL VERSUS SURGICAL ABORTION$0
M01 · FY2002 · RR
COMPARISON OF MEDICAL VERSUS SURGICAL ABORTION$0
M01 · FY2002 · RR
ORAL METHOTREXATE FOR PRIMARY ECTOPIC PREGNANCY THERAPY$0
M01 · FY2002 · RR
ORAL METHOTREXATE FOR PRIMARY ECTOPIC PREGNANCY THERAPY$0
M01 · FY2002 · RR
17DEACETYLNORGESTIMATE, ETHINYL ESTRADIOL W/ ORAL TRIPHA$0
M01 · FY2002 · RR
17DEACETYLNORGESTIMATE, ETHINYL ESTRADIOL W/ ORAL TRIPHA$0
M01 · FY2002 · RR
EVALUATE INSERTION DEVICE FOR TWO ROD LEVONORGESTREL$0
M01 · FY2002 · RR
EVALUATE INSERTION DEVICE FOR TWO ROD LEVONORGESTREL$0
M01 · FY2002 · RR
SPERMICIDAL AGENTS AND COLPOSCOPY AND VAGINAL MICROFLORA$0
M01 · FY2002 · RR
SPERMICIDAL AGENTS AND COLPOSCOPY AND VAGINAL MICROFLORA$0
M01 · FY2002 · RR
CDB 2914 LEVONORGESTREL IN EMERGENCY CONTRACEPTION$0
M01 · FY2002 · RR
CDB 2914 LEVONORGESTREL IN EMERGENCY CONTRACEPTION$0
M01 · FY2002 · RR
SAFETY AND EFFICACY STUDY OF FEMCAP WITH REMOVAL STRAP$0
M01 · FY2002 · RR
SAFETY AND EFFICACY STUDY OF FEMCAP WITH REMOVAL STRAP$0
M01 · FY2002 · RR
POST COITAL TESTING AND SAFETY OF N-9 IN SUPPOSITORIES$0
M01 · FY2002 · RR
POST COITAL TESTING AND SAFETY OF N-9 IN SUPPOSITORIES$0
M01 · FY2002 · RR
LEVONORGESTREL TABLET AS EMERGENCY CONTRACEPTIVE$0
M01 · FY2002 · RR
LEVONORGESTREL TABLET AS EMERGENCY CONTRACEPTIVE$0
M01 · FY2002 · RR
CONTRACEPTIVE EFFECTIVENESS OF SLIP ON PLASTIC CONDOMS$0
M01 · FY2002 · RR
NP9 NOVASOMES VS GYNOL II--VULVAR/VAGINAL/CERVICAL TOX$0
M01 · FY2002 · RR
NP9 NOVASOMES VS GYNOL II--VULVAR/VAGINAL/CERVICAL TOX$0
M01 · FY2002 · RR
SINGLE AND MULTIPLE EXPOSURE TOLERANCE OF CELLULOSE GEL$0
M01 · FY2002 · RR
SINGLE AND MULTIPLE EXPOSURE TOLERANCE OF CELLULOSE GEL$0
M01 · FY2002 · RR
MIFEPRISTONE FOLLOWED ON THE SAME DAY BY MISOPROSTOL$0
M01 · FY2002 · RR
MIFEPRISTONE FOLLOWED ON THE SAME DAY BY MISOPROSTOL$0
M01 · FY2002 · RR
EXPOSURE TOLERANCE OF POLYSTYRENE SULFONATE GEL$0
M01 · FY2002 · RR
EXPOSURE TOLERANCE OF POLYSTYRENE SULFONATE GEL$0
M01 · FY2002 · RR
SOY DIETARY SUPPLEMENT IN VASOMOTOR SYMPTOM THERAPY$0
M01 · FY2002 · RR
SOY DIETARY SUPPLEMENT IN VASOMOTOR SYMPTOM THERAPY$0
M01 · FY2002 · RR
NP9 NOVASOMES VS GYNOL II--VULVAR/VAGINAL/CERVICAL TOX$0
M01 · FY2001 · RR
MIFEPRISTONE FOLLOWED ON THE SAME DAY BY MISOPROSTOL$0
M01 · FY2001 · RR
EXPOSURE TOLERANCE OF POLYSTYRENE SULFONATE GEL$0
M01 · FY2001 · RR
SOY DIETARY SUPPLEMENT IN VASOMOTOR SYMPTOM THERAPY$0
M01 · FY2001 · RR
SPERMICIDAL AGENTS AND COLPOSCOPY AND VAGINAL MICROFLORA$0
M01 · FY2001 · RR
EVALUATE INSERTION DEVICE FOR TWO ROD LEVONORGESTREL$0
M01 · FY2001 · RR
17DEACETYLNORGESTIMATE, ETHINYL ESTRADIOL W/ ORAL TRIPHA$0
M01 · FY2001 · RR
ORAL METHOTREXATE FOR PRIMARY ECTOPIC PREGNANCY THERAPY$0
M01 · FY2001 · RR
COMPARISON OF MEDICAL VERSUS SURGICAL ABORTION$0
M01 · FY2001 · RR
OUTPATIENT TO EVALUATE THE SAFETY OF NORPLANT II$0
M01 · FY2001 · RR
SINGLE AND MULTIPLE EXPOSURE TOLERANCE OF CELLULOSE GEL$0
M01 · FY2001 · RR
CDB 2914 LEVONORGESTREL IN EMERGENCY CONTRACEPTION$0
M01 · FY2001 · RR
SAFETY AND EFFICACY STUDY OF FEMCAP WITH REMOVAL STRAP$0
M01 · FY2001 · RR
POST COITAL TESTING AND SAFETY OF N-9 IN SUPPOSITORIES$0
M01 · FY2001 · RR
LEVONORGESTREL TABLET AS EMERGENCY CONTRACEPTIVE$0
M01 · FY2001 · RR
CONTRACEPTIVE EFFECTIVENESS OF SLIP ON PLASTIC CONDOMS$0
M01 · FY2001 · RR
PHASE II STUDY TO COMPARE CDB-2914 AND LEVONORGESTREL$92,000
N01 · FY2000 · HD
OUTPATIENT TO EVALUATE THE SAFETY OF NORPLANT II$0
M01 · FY2000 · RR
NP9 NOVASOMES VS GYNOL II--VULVAR/VAGINAL/CERVICAL TOX$0
M01 · FY2000 · RR
CONTRACEPTIVE EFFECTIVENESS OF SLIP ON PLASTIC CONDOMS$0
M01 · FY2000 · RR
LEVONORGESTREL TABLET AS EMERGENCY CONTRACEPTIVE$0
M01 · FY2000 · RR
POST COITAL TESTING AND SAFETY OF N-9 IN SUPPOSITORIES$0
M01 · FY2000 · RR
SAFETY AND EFFICACY STUDY OF FEMCAP WITH REMOVAL STRAP$0
M01 · FY2000 · RR
CDB 2914 LEVONORGESTREL IN EMERGENCY CONTRACEPTION$0
M01 · FY2000 · RR
SPERMICIDAL AGENTS AND COLPOSCOPY AND VAGINAL MICROFLORA$0
M01 · FY2000 · RR
EVALUATE INSERTION DEVICE FOR TWO ROD LEVONORGESTREL$0
M01 · FY2000 · RR
17DEACETYLNORGESTIMATE, ETHINYL ESTRADIOL W/ ORAL TRIPHA$0
M01 · FY2000 · RR
ORAL METHOTREXATE FOR PRIMARY ECTOPIC PREGNANCY THERAPY$0
M01 · FY2000 · RR
PHASE II STUDY TO COMPARE CDB-2914 AND LEVONORGESTREL$0
N01 · FY2000 · HD
SOY DIETARY SUPPLEMENT IN VASOMOTOR SYMPTOM THERAPY$0
M01 · FY2000 · RR
EXPOSURE TOLERANCE OF POLYSTYRENE SULFONATE GEL$0
M01 · FY2000 · RR
SINGLE AND MULTIPLE EXPOSURE TOLERANCE OF CELLULOSE GEL$0
M01 · FY2000 · RR